Kaerger J Sebastian, Edge Stephen, Price Robert
Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK.
Eur J Pharm Sci. 2004 Jun;22(2-3):173-9. doi: 10.1016/j.ejps.2004.03.005.
The influence of the size and shape of paracetamol particles on the flow and compression behavior of blends (1:1) of microcrystalline cellulose (MCC) was investigated. The effect of paracetamol particle shape was investigated by using two differently prepared samples, micronized and novel engineered Solution Atomization and Xstallization by Sonication (SAXS) particles, which exhibited similar particle size ranges (2-6 microm). The results were compared to data obtained for an untreated paracetamol sample. The blends containing SAXS particles exhibited increased bulk and tapped density and improved flow, compared to the blend containing micronized particles. This may reflect differences in shape since the SAXS particles exhibited spherical morphology. The compressibility of the blend containing untreated paracetamol was greater than blends containing the SAXS and micronized materials, which may reflect the different drug particle sizes and shapes. However, blends containing the needle-shaped particles of pure untreated sample, exhibited poor compactibility after storage at 10% RH. It was found that increasing the moisture content in the blends by storage at 44% RH resulted in an increase in the compactibility of the samples containing untreated and SAXS paracetamol with the blends containing micronized paracetamol being relatively unaffected. In general, tablets prepared from blends containing smaller particles of paracetamol exhibited significantly greater compactibility compared to tablets prepared containing the larger particle sized untreated paracetamol. The use of small, spherical drug particles may result in improvements in the bulk density, densification and compactibility of blends of paracetamol and microcrystalline cellulose.
研究了对乙酰氨基酚颗粒的大小和形状对微晶纤维素(MCC)混合物(1:1)的流动性和压缩行为的影响。通过使用两种不同制备的样品来研究对乙酰氨基酚颗粒形状的影响,即微粉化样品和新型工程化的超声雾化与结晶法(SAXS)制备的颗粒,这两种颗粒具有相似的粒径范围(2 - 6微米)。将结果与未处理的对乙酰氨基酚样品的数据进行比较。与含有微粉化颗粒的混合物相比,含有SAXS颗粒的混合物表现出更高的堆密度和振实密度以及更好的流动性。这可能反映了形状上的差异,因为SAXS颗粒呈现球形形态。含有未处理对乙酰氨基酚的混合物的可压缩性大于含有SAXS和微粉化材料的混合物,这可能反映了不同的药物粒径和形状。然而,含有纯未处理样品的针状颗粒的混合物在10%相对湿度下储存后表现出较差的压片性能。发现通过在44%相对湿度下储存来增加混合物中的水分含量,会导致含有未处理和SAXS对乙酰氨基酚的样品的压片性能增加,而含有微粉化对乙酰氨基酚的混合物相对不受影响。一般来说,与由较大粒径的未处理对乙酰氨基酚制备的片剂相比,由含有较小粒径对乙酰氨基酚颗粒的混合物制备的片剂表现出显著更高的压片性能。使用小的球形药物颗粒可能会改善对乙酰氨基酚与微晶纤维素混合物的堆密度、致密化和压片性能。